Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceNIRXCELL PMS US STUDY NIRTRAKS
Generic NameSTENT, CORONARY
ApplicantMEDINOL LTD.
KIRYAT ATIDIM, BLDG. 7
ENTRANCE A, P.O.B. 58165
TEL-AVIV 61581
PMA NumberP110004
Supplement NumberS021
Date Received12/05/2016
Decision Date02/10/2017
Withdrawal Date 11/02/2020
Product Code MAF 
Advisory Committee Cardiovascular
Supplement TypeNormal 180 Day Track No User Fee
Supplement Reason Postapproval Study Protocol - OSB
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
Approval for cessation of patient enrollment in this PAS for the post-approval study (PAS).
-
-